However, neither obesity nor activation of IL-6/STAT3 cause cancer on their own, but increase the possibility of progression to cancer of hepatocytes that have earlier acquired an oncogenic mutation [84]. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.